Oxford Immunotec to Present at the Baird 2016 Global Healthcare Conference
August 24 2016 - 3:15PM
OXFORD, United Kingdom and
MARLBOROUGH, Mass., Aug. 24, 2016 (GLOBE NEWSWIRE) -- Oxford
Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth
diagnostics company focused on developing and commercializing
proprietary tests for the management of immune-regulated
conditions, today announced that Rick Altieri, Chief Financial
Officer, will present at the Baird 2016 Global Healthcare
Conference on Wednesday, September 7, 2016, at 2:35 p.m. ET at the
New York Palace in New York, NY.
About Oxford Immunotec
Oxford Immunotec Global PLC is a
global, high-growth diagnostics company focused on developing and
commercializing proprietary tests for the management of
immune-regulated conditions. The Company's first product is
the T-SPOT®.TB test, which is used to
test for tuberculosis infection. The T-SPOT.TB test has been approved
for sale in over 50 countries, including the United States, where
it has received pre-market approval from the Food and Drug
Administration, Europe, where it has obtained a CE mark, as well as
Japan and China. The T-SPOT.CMV test and the T-SPOT.PRT test are the Company's
second and third products and part of a series of products intended
for the transplantation market. In addition to these three
products, the Company has an additional six active development
programs, each of which leverages our T cell, B cell and innate
immune measuring technology. The Company is headquartered
near Oxford, U.K. and in Marlborough, Mass. Additional information
can be found at www.oxfordimmunotec.com.
T-SPOT and the Oxford
Immunotec logo are trademarks of Oxford Immunotec
Ltd.
CONTACTS:
For Media Inquiries:
Caroline
Crawley
Oxford Immunotec
Tel: +44 1235 442796
ccrawley@oxfordimmunotec.com
For Investor Inquiries:
Rick Altieri
Chief Financial Officer
Oxford Immunotec
Tel: +1 (508) 573-9953
raltieri@oxfordimmunotec.com
Mark Klausner
Westwicke Partners
Tel: +1 (443) 213-0501
oxfordimmunotec@westwicke.com
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Oxford Immunotec via Globenewswire
HUG#2037145
Oxford Immunotec Global (NASDAQ:OXFD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Oxford Immunotec Global (NASDAQ:OXFD)
Historical Stock Chart
From Sep 2023 to Sep 2024